Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2007
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654098A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/20/2007US20070293668 Phenylindoles for the treatment of HIV
12/20/2007US20070293667 Such as (7-chloro-2-styryl-quinazolin-4-yl)-(3-imidazol-1-yl-propyl)-amine; glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
12/20/2007US20070293545 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293499 Intracellular Kinase Inhibitors
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293497 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293494 2-Anilino-4-(Heterocyclic) Amino-Pyrimidines
12/20/2007US20070293493 Oxazolidinone antibiotics and derivatives thereof
12/20/2007US20070293492 Quinoline Tachykinin Receptor Antagonists
12/20/2007US20070293490 Quinazoline Derivatives
12/20/2007US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis
12/20/2007US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
12/20/2007US20070293486 Alpha-Keto Carbonyl Calpain Inhibitors
12/20/2007US20070293484 Thiophene Heteroaryl Amines
12/20/2007US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses
12/20/2007US20070293472 Novel 14 and 15 Membered Ring Compounds
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/20/2007US20070290610 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
12/19/2007EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
12/19/2007EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
12/19/2007EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
12/19/2007EP1866311A2 Novel compounds
12/19/2007EP1866294A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses
12/19/2007EP1866293A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1865959A2 Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
12/19/2007EP1865958A2 Pharmacokinetically improved compounds
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1711480B1 Novel long-working beta-2-agonists and use thereof as medicaments
12/19/2007EP1670792B1 Process for the preparation of chiral propionic acid derivatives
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007CN101090908A Conjugates with anti-inflammatory activity
12/19/2007CN101090899A 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors
12/19/2007CN101088998A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/19/2007CN100355752C 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309802 Preparation of isoxazolin-3-ylacylbenzene
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/13/2007WO2007142207A1 Process for production of 4-substituted azetidinone derivatives
12/13/2007WO2007141517A1 Benzimidazoles and their use for the treatemnt of diabetes
12/13/2007WO2007141318A1 2,5-disubstituted piperidines
12/13/2007WO2007140982A1 Substituted benzoxazoles
12/13/2007WO2007044796A3 Pyridazinone compounds as calcilytics
12/13/2007US20070287736 Diphenyl Substituted Alkanes as Flap Inhibitors
12/13/2007US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors
12/13/2007US20070287707 Phosphodiesterase 10 inhibitors
12/13/2007US20070287699 Antiviral agents
12/13/2007US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
12/13/2007DE102006027163A1 Substituierte Benzoxazole Substituted benzoxazole
12/13/2007CA2660667A1 2,5-disubstituted piperidines
12/13/2007CA2655225A1 Benzimidazoles and their use for the treatemnt of diabetes
12/12/2007EP1864982A1 Triamine derivative
12/12/2007EP1864976A1 Propane-1,3-dion derivative or salt thereof
12/12/2007EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/12/2007EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863803A2 Substituted piperidines
12/12/2007EP1863802A1 Substituted piperidines as renin inhibitors
12/12/2007EP1863801A2 Benzimidazole derivative and use thereof
12/12/2007EP1863799A1 Cgrp-antagonists, process for their preparation as well as their use as medicaments
12/12/2007EP1863787A1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863764A1 Process for the preparation of opioid modulators
12/12/2007EP1863763A1 3,4,5-substituted piperidines as renin inhibitors
12/12/2007EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
12/12/2007EP1863474A1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
12/12/2007EP1725526B1 Method for preparing pyrrolidine oximes
12/12/2007EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007CN101087784A Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
12/12/2007CN101087777A Pyrrolidinium derivatives as M3 muscarinic receptors
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101087609A Factor Xa compounds
12/12/2007CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 647